scholarly article | Q13442814 |
P50 | author | Faramarz Ismail-Beigi | Q98918532 |
P2093 | author name string | Manuel Lombardero | |
Saul Genuth | |||
Joel Zonszein | |||
Pasquale Palumbo | |||
Gary Cushing | |||
Bari 2D Study Group | |||
Bernardo Wajchenberg | |||
Suzy Foucher | |||
Yolanda Groenewoud | |||
P2860 | cites work | Prevalence and identification of abnormal lipoprotein levels in a biracial population aged 23 to 35 years (the CARDIA Study). The Coronary Artery Risk Development in Young Adults Study. | Q51016459 |
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group | Q56914456 | ||
Changes in diabetes-related complications in the United States, 1990-2010 | Q64125961 | ||
(7) Approaches to glycemic treatment | Q86396528 | ||
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 | ||
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes | Q28254549 | ||
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Q29619886 | ||
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy | Q29620534 | ||
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial | Q30438736 | ||
A randomized trial of therapies for type 2 diabetes and coronary artery disease | Q33827504 | ||
Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. | Q33901958 | ||
Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis | Q34142893 | ||
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis | Q34634794 | ||
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials | Q34686089 | ||
The global spread of type 2 diabetes mellitus in children and adolescents. | Q36116070 | ||
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs. | Q36297873 | ||
Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? | Q36539179 | ||
Type 2 diabetes in youth: epidemiology and pathophysiology | Q36783734 | ||
Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). | Q37022623 | ||
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease | Q38250379 | ||
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. | Q41275648 | ||
Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know | Q42362563 | ||
The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease | Q43109231 | ||
Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant | Q44659546 | ||
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? | Q45266146 | ||
Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations | Q45931171 | ||
Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans | Q46458608 | ||
Ethnic differences in the ability of triglyceride levels to identify insulin resistance | Q46751189 | ||
Individuals with high total cholesterol/HDL cholesterol ratios are insulin resistant | Q47972709 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | preproinsulin | Q7240673 |
triglyceride | Q186319 | ||
type 2 diabetes | Q3025883 | ||
P304 | page(s) | 129891 | |
P577 | publication date | 2015-05-27 | |
P1433 | published in | Journal of Diabetes Research | Q26841822 |
P1476 | title | Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D. | |
P478 | volume | 2015 |